ArticleScientific reports2026
Unraveling the anthelmintic efficacy of Curcuma amada Roxb. extract: A multi-modal mechanistic study against Raillietina spp. infection.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study describes the cellular impact of Curcuma amada Roxb. extract on the poultry tapeworm Raillietina spp. The ethanolic crude extract (ECE) and ethyl acetate fraction (EAF) were evaluated for their anthelmintic efficacy other than Curcumin and compared to the conventional drug praziquantel (PZQ). Phytochemical analysis of the EAF using GC-MS (Gas Chromatography-Mass Spectrometry) and FTIR (Fourier transform infrared spectroscopy) identified key bioactive compounds, with [2,4-Di-tert-butylphenol] being the most prominent. Single-cell suspensions from the parasite were treated with ECE and PZQ, and subsequent assays revealed significant DNA damage, mitochondrial membrane destabilization, loss of lysosomal membrane integrity, and reduced cell viability. Scanning and transmission electron microscopy confirmed extensive ultrastructural damage to both external and internal tissues. Furthermore, cytological examination showed structural alterations in encapsulated eggs after ECE treatment, suggesting a reduction in infectivity. Overall, these findings highlight the promising anthelmintic potential of Curcuma amada rhizome extracts, mediated through profound subcellular and morphological disruption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.